Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Boji Medical Technology Co., Ltd.
Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
service content
Video
  • Company News
  • Industry News
  • Regulations and Policies
  • Boji Medical Technology Co., Ltd appeared at the 10th Lingnan Organic Chemistry Forum and Star Enterprise Drug Innovation Forum
    2021/12/07
    Recently, the 10th Lingnan Organic Chemistry Forum and Star Enterprise Drug Innovation Forum ,hosted by the Chemical Society of Guangdong Province and undertaken by the School of Pharmacy of Jinan University was held in Nanyang Changsheng Hotel, Guangzhou. Zuo Lian, deputy general manager of Boji Medical Technology Co., Ltd, and her team made a major appearance at the event, and delivered a speech on the theme of "Research Status and Enlightenment of Innovative Drugs at Home and Abroad" at the meeting.
  • Boji Medical Technology Co., Ltd attended the academic exchange meeting on the research and development of Guangdong Provincial transdermal drug delivery systems
    2021/12/07
    Recently, the Guangdong Provincial Transdermal Drug Preparation Research and Development Academic Exchange Conference and the inaugural meeting of the Transdermal Drug Association Professional Committee of the Guangdong Provincial Traditional Chinese Medicine were held in the Guangzhou Dongshan Hotel Conference Center. Boji Medical Technology Co., Ltd participated in the meeting as a co-organizer.During the meeting, the Transdermal Drug Delivery Committee of the Guangdong Provincial Traditional Chinese Medicine released the list of the first appointed members. Ma Renqiang, deputy general manager of Boji Medical Technology Co., Ltd, was appointed as the standing member of the first committee of the Transdermal Drug Delivery Committee of the Guangdong Provinvial Traditional Chinese Medicine. Dr. Li Jingrong, director of Boji Medical Drug Evaluation Center, delivered a keynote speech entitled "Preclinical Evaluation of Skin External Preparations" at the meeting.
Boji pharmaceutical
  • Founding Time
    Founded in 2002
  • Industry
    Contract Research Organization
  • Market Status
    Leading domestic CRO enterprises; International and well-known companies
  • Number Of Employees
    More than 700 pharmaceutical researchers
  • Development History

    After 18 years of development, Boji Pharmaceutical has ranked among China's CRO companies in terms of technical strength, service quality, service scope, operating income, team building.


  • Company Culture

    Strategic goals: Consolidate domestic leadership, achieve international leadership and build acentury-old brand.

    Business philosophy: Think for customers, serve customers, make progress together with customers.


Cooperation Agency

Our company always adheres to the concept of "professional, honest, enterprising and harmonious". After nearly a decade of clinical research in new drugs, our company has achieved rapid development.


  • Phone:400-0020-628
  • Address:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer